Futuresearch Trials Of Neurology
Austin, Texas 78756
15 studies enrolling now · 89 studies all time
What they study most
Acute Migraine, Acute Treatment of Migraine, Alzheimer Disease, Alzheimer's Disease, Analgesia, Arthritis, Behavioral Variant Frontotemporal Dementia, Cataplexy, Chronic Low Back Pain, Chronic Low Back Pain (CLBP), Chronic Low-back Pain, Chronic Noncancer Pain
Studies at this site
- A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight — Recruiting now
- A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine — Recruiting now
- A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine — Recruiting now
- Maridebart Cafraglutide Versus Placebo in Adult Participants With Obstructive Sleep Apnea on Positive Airway Pressure Therapy — Recruiting now
- A Study to Learn About the Safety of Taking an Additional Dose of the Medicine Rimegepant in Adults With Migraine — Recruiting now
- A Study to Learn About the Study Medicine Called Rimegepant in Women When Used for Intermittent Prevention of Menstrual Migraine — Recruiting now
- A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Diabetic Peripheral Neuropathic Pain — Recruiting now
- Study of EVO756 in Adults With Migraine — Recruiting now
- A Master Protocol Study (LY900028) of Multiple Intervention-Specific-Appendices (ISAs) in Participants With Chronic Pain — Recruiting now
- Maridebart Cafraglutide Versus Placebo in Adult Participants With Obstructive Sleep Apnea Not on Positive Airway Pressure (PAP) Therapy — Recruiting now
- A Study to Evaluate the Efficacy and Safety of E2086 in Adults With Narcolepsy — Recruiting now
- A Study to Investigate the Treatment Effect of Subcutaneous Injections of Pentosan Polysulfate Sodium Compared With Placebo in Adult Participants With Knee Osteoarthritis Pain. — Recruiting now
- A Study of LY3556050 in Adult Participants With Diabetic Peripheral Neuropathic Pain — Completed
- A Study of Retatrutide (LY3437943) in Participants With Type 2 Diabetes Mellitus Who Have Obesity or Overweight — Completed
- A Study of Retatrutide (LY3437943) in Participants Who Have Obesity or Overweight and Chronic Low Back Pain — Running, not enrolling
- A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Chronic Low Back Pain — Starting soon
- A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Osteoarthritis Pain — Starting soon
- Study of SDX in Patients With Idiopathic Hypersomnia (IH) — Completed
- A Study of Enicepatide (CT-388) in Participants Who Are Overweight or Obese With Type 2 Diabetes Mellitus — Running, not enrolling
- A Study of Retatrutide (LY3437943) in Participants Who Have Obesity or Overweight — Completed
- A Switch Study From High-Sodium Oxybate to Xywav to Evaluate Changes in Blood Pressure in Participants With Narcolepsy — Completed
- Erenumab - Comprehensive Assessment of Efficacy in (High-Frequency) Episodic Migraine — Completed
- Efficacy and Safety Trial of BHV-2100 for the Acute Treatment of Migraine — Completed
- A Study of ONO-2020 in Participants With Mild to Moderate Alzheimer's Disease — Running, not enrolling
- Efficacy and Safety Study of Rimegepant in Episodic Migraine Prevention With Multiple Dosing Regimens — Completed
- A Study of RTA 901 (BIIB143) in Participants With Diabetic Peripheral Neuropathic Pain — Stopped early
- A Study of Maridebart Cafraglutide in Adult Participants With Type 2 Diabetes Mellitus (T2DM) — Running, not enrolling
- Parallel-Arm Study to Compare AD109 to Placebo With Patients With OSA (SynAIRgy Study) — Completed
- Parallel Arm Trial of AD109 and Placebo With Patients With OSA (LunAIRo) — Completed
- An Open Label Study of FT218 in Subjects With Narcolepsy — Completed
- A Master Protocol for Orforglipron in Participants With Obstructive Sleep Apnea and Obesity or Overweight — Running, not enrolling
- A Study to Investigate the Effect of XYWAV on Sleepiness, Polysomnography, and Functional Outcomes in Participants With Idiopathic Hypersomnia or Narcolepsy — Completed
- Simufilam 100 mg for Mild-to-Moderate Alzheimer's Disease — Completed
- Continuation Protocol for Obstructive Sleep Apnea (OSA) — Enrolling by invitation
- Obstructive Sleep Apnea Master Protocol GPIF: A Study of Tirzepatide (LY3298176) in Participants With Obstructive Sleep Apnea — Completed
- A Study to Evaluate the Efficacy and Safety of Oral Zavegepant in Migraine Prevention — Stopped early
- A Study to Evaluate Safety, and Efficacy of SUVN-G3031 (Samelisant) in Patients With Narcolepsy With and Without Cataplexy — Completed
- Noninvasive Peripheral Nerve Stimulation for Medication-Refractory Primary RLS (The RESTFUL Study) — Completed
- Extension Study Evaluating NTX100 Neuromodulation System for Medication-Refractory Primary RLS — Completed
- A Chronic Pain Master Protocol (CPMP): A Study of LY3857210 in Participants With Diabetic Peripheral Neuropathic Pain (NP05). — Completed
- A Study of Galcanezumab (LY2951742) in Adult Participants With Episodic Migraine — Completed
- A Chronic Pain Master Protocol (CPMP): A Study of LY3857210 In Participants With Osteoarthritis Pain — Completed
- An Interventional Safety Switch Study (Segue Study) of XYWAV in Narcolepsy — Completed
- A Randomized, Double-Blind, Parallel Group, Placebo-Controlled Study to Assess STS101 in the Acute Treatment of Migraine — Completed
- Efficacy and Safety of ETX-018810 for the Treatment of Diabetic Peripheral Neuropathic Pain — Completed
- Acute Treatment Trial in Adult Subjects With Migraines — Completed
- Ricolinostat in Patients With Painful Diabetic Peripheral Neuropathy — Completed
- A Study to Evaluate the Safety of STS101 in the Acute Treatment of Migraine — Completed
- A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate STS101 in the Acute Treatment of Migraine — Completed
- Open-Label Study of Leuco-methylthioninium Bis(Hydromethanesulfonate) (LMTM) in Subjects With Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia (bvFTD) — Stopped early